Six early-career professors win NSF development awards

Researchers studying large-scale artificial intelligence, microbial biomanufacturing and causal inference methods are among the Cornell researchers who recently received National Science Foundation Faculty Early Career Development Awards.

Genetic signature may predict lung cancer response to immunotherapy

A new study has identified a set of 140 genes that may help predict enhanced disease-free survival in patients with non-small-cell lung cancer treated with a combination of immunotherapy and low-dose radiation.

New insight into old IBD drug could improve treatments

Weill Cornell researchers find inflammatory bowel disease drug works by modulating the activity of a group of gut bacteria that are more abundant in patients who respond to the drug.

Navigating the future of product development

Cornell Tech experts Keith Cowing and Josh Hartmann offer a preview of the 2024 Product and Tech Leadership Summit.

Around Cornell

Blockchains kill in Cornell Tech professor’s thriller novel

A confluence of events, combined with a healthy obsession for details and a love of writing, gave Cornell Tech computer scientist Ari Juels just what he needed to produce his second fiction thriller, “The Oracle.”

Vaccine shows promise against CMV, a virus that causes birth defects

An experimental mRNA vaccine against human cytomegalovirus, a common virus that can infect babies during pregnancy, elicited some of the most promising immune responses to date of any vaccine candidate, according to a study by Weill Cornell Medicine investigators.

Apixaban no better than aspirin for preventing some strokes

A multicenter, phase 3 clinical trial has found that apixaban is no more effective than aspirin at preventing a second stroke in patients diagnosed with a milder, related condition called atrial cardiopathy, according to new research.

NIH grant awarded for study of key membrane proteins

Alessio Accardi, professor of physiology and biophysics in anesthesiology at Weill Cornell Medicine, has been awarded a five-year, $2.7 million grant for fundamental research on cell membrane proteins that have critical roles in biology and are involved in numerous human diseases.